You are here

Article Text

Article menu
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Anomalous origin and aneurysm of the suprascapular artery: the first case observed
  1. Enrico M Zardi1,
  2. Federico Bucci2,
  3. Domenico M Zardi3,
  4. Raffaele Capoano2,
  5. Filippo Maria Salvatori4,
  6. Luciana Tromba2,
  7. Antonio Amoroso5
  1. 1
    Campus Bio-Medico University, Clinical Medicine, Via Àlvaro del Portillo, 200, Rome, 00128, Italy
  2. 2
    I Faculty of Medicine, University of Rome “La Sapienza”, Department of Surgical Sciences, Via del Policlinico 155, Rome, 00161, Italy
  3. 3
    II Faculty of Medicine, Sant’Andrea Hospital, University of Rome “La Sapienza”, Division of Cardiology, Via Di Grottarossa 1035, Rome, 00185, Italy
  4. 4
    I Faculty of Medicine, University of Rome, Department of Vascular and Interventional Radiology, Via del Policlinico 155, Rome, 00161, Italy
  5. 5
    I Faculty of Medicine, University of Rome “La Sapienza”, Department of Clinical Medicine, Via del Policlinico 155, Rome, 00161, Italy
  1. e.zardi{at}unicampus.it

Summary

A 45-year-old woman was referred to our department having suddenly developed, 9 months earlier, a pulsating mass on the right supraclavicular fossa and torticollis. Colour Doppler sonography and computed tomographic angiography showed the presence of an aneurysm (21 mm in diameter) of the suprascapular artery that had an anomalous origin from the subclavian artery. Thoracic outlet syndrome was excluded. After selective arteriography, the aneurysm of the suprascapular artery was successfully treated with ethylene-vinyl alcohol polymer (Onyx, MicroTherapeutics, Irvine, California, USA), a liquid embolic agent. The patient was discharged on the first postoperative day in good condition. Control colour Doppler sonography at 1 year confirmed the complete thrombosis of the aneurysm sac.

https://doi.org/10.1136/bcr.09.2008.0869

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: None.

    • Patient consent: Patient/guardian consent was obtained for publication.